Efficacy of Lazolex® Gel in the Treatment of Herpes Simplex Mucocutaneous Infections and the Prevention of Recurrences: A Pilot Study

<div>Visual chart for herpes labialis progression in a 27-year-old female infected with HSV-1.</div>

Canadian Journal of Infectious Diseases and Medical Microbiology

Figure 3: Efficacy of Lazolex® Gel in the Treatment of Herpes Simplex Mucocutaneous Infections and the Prevention of Recurrences: A Pilot Study 